Dr Clarissa Whitehead

Clarissa has a strong background in both academic and industry biomedical research environments. She is passionate about translational research and innovative biotechnology that can improve the lives of patients and shape the future of healthcare.
 
She completed her PhD at The University of Melbourne in 2021, during which she investigated disease progression in malignant glioma and response to treatment as part of the Brain Cancer Invasion Group. Following this, she worked as a lead R&D scientist at a publicly traded biotechnology company to support the company’s pre-clinical drug development pipelines across a range of disease settings, including cancer and infectious disease. 

• 2021: PhD, The University of Melbourne, Australia
• 2016: BSc (Hons), The University of Melbourne, Australia

• 2023-current: Senior Research Officer, Burnet Institute, Victoria, Australia.
• 2022-2023: Senior Research Scientist, Exopharm Ltd, Victoria, Australia.
• 2021-2022: Research Scientist, Exopharm Ltd, Victoria, Australia.